Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

European Journal of Cancer

Volumn 44, Issue 4, 2008, Pages 557-564

  Bardin, A ^a   Vaccarella, S ^b   Clifford, G M ^b   Lissowska, J ^a   Rekosz, M ^a   Bobkiewicz, P ^a   Kupryjanczyk J ^a   Krynicki, R ^a   Jonska Gmyrek, J ^a   Danska Bidzinska, A ^a   Snijders, P J F ^c   Meijer, C J L M ^c   Zatonski, W ^a   Franceschi, S ^b  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cervical cancer; Epidemiology; Human papillomavirus; Poland

Indexed keywords

VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PARITY; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; MARITAL STATUS; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRUS INFECTIONS; POLAND; PREVALENCE; RISK FACTORS; SEXUAL PARTNERS; UTERINE CERVICAL NEOPLASMS;

EID: 40249111662     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.12.001     Document Type: Article

References (23)

1. Parkin DM, Whelan SL, Ferlay J, Thomas DB, Teppo L, editors. Cancer incidence in five continents, Vol. VIII. IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer; 2002.
2. Levi F., Lucchini F., Negri E., Franceschi S., and La Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer 36 (2000) 2266-2271
3. Rekosz M., Karska A., Osiecka-Tesny E., Jackowska A., and Wojcinska M. 15 years of active cervical cancer screening done by the Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology in Warsaw - results obtained to-date. Nowotwory Journal of Oncology 53 (2003) 62-69
4. Cuzick J., Clavel C., Petry K.U., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119 (2006) 1095-1101
5. Kahn J.A., and Burk R.D. Papillomavirus vaccines in perspective. Lancet 369 (2007) 2135-2137
6. Clifford G.M., Gallus S., Herrero R., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
7. Franceschi S., Herrero R., Clifford G.M., et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 119 (2006) 2677-2684
8. Kornya L., Cseh I., Deak J., Bak M., and Fulop V. The diagnostics and prevalence of genital human papillomavirus (HPV) infection in Hungary. Eur J Obstet Gynecol Reprod Biol 100 (2002) 231-236
9. Syrjanen S., Shabalova I., Petrovichev N., et al. Sexual habits and human papillomavirus infection among females in three New Independent States of the former Soviet Union. Sex Transm Dis 30 (2003) 680-684
10. Snijders P.J.F., van den Brule A.J.C., Jacobs M.V., Pol R.P., and Meijer C.J.L.M. HPV DNA detection and typing in cervical scrapes by general primer GP5+/6+ PCR. Methods in molecular medicine Volume 119: Human papillomaviruses - methods and protocols (2005), Humana Press, Totowa 101-114
11. Roda Husman A.M., Snijders P.J., Stel H.V., van den Brule A.J., Meijer C.J., and Walboomers J.M. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 72 (1995) 412-417
12. Jacobs M.V., Walboomers J.M., Snijders P.J., et al. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87 (2000) 221-227
13. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40 (2002) 779-787
14. Muñoz N., Bosch F.X., de Sanjosé S., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348 (2003) 518-527
15. Ronco G., Ghisetti V., Segnan N., et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 41 (2005) 297-305
16. Giuliano A.R., Papenfuss M., Abrahamsen M., et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 10 (2001) 1129-1136
17. Vaccarella S., Franceschi S., Herrero R., et al. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev 15 (2006) 326-333
18. Vaccarella S., Herrero R., Dai M., et al. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys. Cancer Epidemiol Biomarkers Prev 15 (2006) 2148-2153
19. Liss J., Lukaszuk K., Gulczynski J., et al. The incidence of human papilloma virus (HPV) DNA in patients with cervical carcinoma from Gdansk region. Ginekol Pol 73 (2002) 740-744
20. Dybikowska A., Licznerski P., and Podhajska A. HPV detection in cervical cancer patients in northern Poland. Oncol Rep 9 (2002) 871-874
21. Franceschi S., and Clifford G.M. Re: A study of the impact of adding HPV types to cervical cancer screening and triage tests. J Natl Cancer Inst 97 (2005) 938-939
22. Shin H.R., Lee D.H., Herrero R., et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 103 (2003) 413-421
23. Sukvirach S., Smith J.S., Tunsakul S., et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187 (2003) 1246-1256